Safe allergen immunotherapy: The correct allergen, the appropriate patient, the adequate dose

Postgraduate Medicine

Volumn 100, Issue 2, 1996, Pages

  Schoenwetter, William F ^a  

^a PARK NICOLLET CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ALLERGY; ANAPHYLAXIS; CONFERENCE PAPER; HUMAN; IMMUNOTHERAPY; PATIENT SELECTION; SAFETY; STANDARDIZATION; STORAGE;

EID: 9444280143     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1996.08.54     Document Type: Conference Paper

References (17)

1. Van Metre TE Jr, Adkinson NF Jr. Immunotherapy for aeroallergen disease. In: Middleton E Jr, Reed CE, Ellis EF, et al, eds. Allergy: principles and practice. 4th ed. St Louis: Mosby-Year Book, 1993:1489-510
2. Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995;151(4):969-74
3. Müller U, Berchtold E, Helbling A. Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 1991;87(3):702-9
4. Frew AJ, for the British Society for Allergy and Clinical Immunology Working Party. Injection immunotherapy. BMJ 1993; 307(6909):919-23
5. Nelson HS, Oppenheimer J, Vatsia GA, et al. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993;92(2):229-36
6. Council on Scientific Affairs, American Medical Association. Clinical ecology. JAMA 1992;268(24):3465-7
7. Taudorf E, Laursen LC, Lanner A, et al. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987;80(2):153-61
8. Creticos PS. Immunologic changes associated with immunotherapy. Immunol Allergy Clin North Am 1992;12(1):13-20
9. 1 pp 529-34
10. Iliopoulos O, Proud D, Adkinson NF Jr, et al. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991;87(4):855-66
11. Bousquet J, Michel FB. Specific immunotherapy in allergic rhinitis and asthma. In: Busse WW, Holgate ST, eds. Asthma and rhinitis. St Louis: Mosby-Year Book, 1995:1309-15
12. 1 pp 1511-24
13. Hedlin G, Graff-Lonnevig V, Heilborn H, et al. Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment. J Allergy Clin Immunol 1991;87(5):955-64
14. Hedlin G, Heilborn H, Lilja G, et al. Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995;96(6 Pt 1):879-85
15. Nelson HS. Effect of preservatives and conditions of storage on the potency of allergy extracts. J Allergy Clin Immunol 1981;67(1):64-9
16. Du Buske LM, Ling CJ, Sheffer AL. Special problems regarding allergen immunotherapy. Immunol Allergy Clin North Am 1992;12(1): 145-51
17. Reid MJ, Lockey RF, Turkeltaub PC, et al. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993;92(1 Pt 1):6-15